Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Waldeck, S
Title
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.
Citation
Molecular oncology; 2020 Apr; 14(4) pg779-794
PubMed ID
31955503
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
500-P36
Human
in vitro
900-K33
Human
ELISA
900-M92
Human
ELISA
First Author
Fitch, N
Title
Vitamin D [1,25(OH)2D3] Differentially Regulates Human Innate Cytokine Responses to Bacterial versus Viral Pattern Recognition Receptor Stimuli.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2016 Apr 1; 196(7) pg2965-72
PubMed ID
26895836
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P35
Human
ELISA
500-P36
Human
ELISA
500-P20
Human
ELISA
500-P34
Human
ELISA
First Author
Øynebråten, I
Title
Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells.
Citation
Scientific Reports; 2015 Mar 20; 5 pg9261
PubMed ID
25791723
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P36
Human
Immunostaining
First Author
Franciszkiewicz, K
Title
Synaptic release of CCL5 storage vesicles triggers CXCR4 surface expression promoting CTL migration in response to CXCL12.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2014 Nov 15; 193(10) pg4952-61
PubMed ID
25305322
Show Usages
Product Cited
Cross-Reactivity
Applications
300-06
Human
in vitro
500-P36
Human
Immunostaining
First Author
Raposo, R A
Title
Protein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infection.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2011 Jul 15; 187(2) pg748-59
PubMed ID
21666058
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P06
Human
Neutralization
500-P36
Human
Neutralization
First Author
Rius, C
Title
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2010 Sep 15; 185(6) pg3718-27
PubMed ID
20709957
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P28
Human
ELISA
500-P28BT
Human
ELISA
500-P34
Human
ELISA
500-P34BT
Human
ELISA
200-08M
Human
ELISA
300-04
Human
ELISA
300-06
Human
ELISA
300-08
Human
ELISA
500-P36
Human
ELISA
500-P36BT
Human
ELISA
200-08M
Human
in vitro
300-04
Human
in vitro
300-06
Human
in vitro
300-08
Human
in vitro
500-P38
Human
ELISA
500-P38BT
Human
ELISA
400-12
Rat
ELISA
400-15
Rat
ELISA
500-P77
Rat
ELISA
500-P76
Rat
ELISA
500-P76BT
Rat
ELISA
500-P77BT
Rat
ELISA
400-12
Rat
in vitro
400-15
Rat
in vitro
First Author
Roscic-Mrkic, B
Title
RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement.
Citation
Blood; 2003 Aug 15; 102(4) pg1169-77
PubMed ID
12714503
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P36
Human
Western Blot
First Author
Blumenthal, R D
Title
Degranulating eosinophils in human endometriosis.
Citation
The American Journal of Pathology; 2000 May; 156(5) pg1581-8
PubMed ID
10793070
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P36
Human
Immunostaining
500-P41
Human
Immunostaining
showing 8 of 8